Safety and Efficacy of Ultrasound Renal Denervation in Kidney Transplantation Patients With Uncontrolled Hypertension — RESTART  

Hypertension Clinical Trial

Official title: Safety and Efficacy of Ultrasound Renal Denervation in Kidney Transplantation Patients With Uncontrolled Hypertension: the RESTART Study

Status Not yet recruiting

Clinical Trial Summary

This prospective, single-arm, interventional study is designed to assess the short-term and long-term safety and efficacy of bilateral ultrasound renal sympathetic denervation (RDN) of the native kidneys in renal transplant patients with uncontrolled hypertension.

Objectives:

• To assess the short-term and long-term changes in ambulatory and office blood pressure (BP) following native kidney RDN in renal transplant patients

• To assess the long-term safety of native kidney RDN in renal transplant patients

• To assess the short-term and long-term change in antihypertensive drug prescriptions following native kidney RDN in renal transplant patients

• To assess the short-term and long-term change in adherence to antihypertensive drugs following native kidney RDN in renal transplant patients

Clinical Trial Description

The RESTART study is an investigator-initiated, prospective, single-center, single-arm interventional study investigating the safety and efficacy of bilateral native kidney RDN in 40 renal transplant patients with uncontrolled hypertension despite antihypertensive medication (or with a documented intolerance to antihypertensive drugs).

Previously, RDN demonstrated to safely reduce BP as compared to sham-control in multiple randomized clinical trials, both in patients with and without concomitant antihypertensive medication. Up until now, patients with a history of renal failure or kidney transplantation have been excluded from these studies. As the pathophysiology of hypertension is considered different in hypertensive renal transplant patients as compared to the previously studied populations (without kidney transplantation), the effect of native kidney RDN in hypertensive patients with a history of kidney transplantation remains unknown. The current study aims to provide novel insights on the safety and efficacy of RDN in this particular population. Adjustment for routine therapy adherence will also be performed as this proved to be an important confounding factor in previous research. ;

Related Conditions & MeSH terms

• Hypertension
• Kidney Transplantation

• NCT number: NCT05934383
• Study type: Interventional
• Source: Erasmus Medical Center
• Contact: Joost Daemen, MD PhD
• Phone: +31107040704
• Email: j.daemen@erasmusmc.nl
• Status: Not yet recruiting
• Phase: N/A
• Start date: September 2023
• Completion date: September 2030